postpartum depression

news

First oral medicine for postpartum depression approved

7 August 2023 | By Catherine Eckford (European Pharmaceutical Review)

The first approved oral treatment that provides rapid symptomatic improvement in postpartum depression (PPD) is expected to be commercially available in the fourth quarter of 2023.

news

Novel pill could aid postpartum depression symptoms

28 July 2023 | By Catherine Eckford (European Pharmaceutical Review)

If approved, the treatment could provide the first oral, at-home, neuroactive steroid therapy to treat postpartum depression (PPD).

news

Natural allopregnanolone made orally bioavailable

8 March 2023 | By Catherine Eckford (European Pharmaceutical Review)

Designed to treat anxiety and postpartum depression, a biotherapeutics company has made natural allopregnanolone orally bioavailable without permanent chemical modification.

news

Injection could help postpartum depression, says study

29 September 2022 | By Catherine Eckford (European Pharmaceutical Review)

Data demonstrated that a one-time injection of the drug BRII-296 is safe and effective for most patients with postpartum depression (PPD).